A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-684
Published Online: 2014-09-20
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Jin-Ji
Huang, Cheng
Chen, Gong-Yan
Song, Yong
Cheng, Ying
Yan, Hong-Hong
Zhou, Qing
Wu, Yi-Long
License valid from 2014-09-20
Article History
Received: 20 May 2013
Accepted: 17 September 2014
First Online: 20 September 2014